Advertisement

Topics

Lycera Corp. Company Profile

01:41 EST 10th December 2018 | BioPortfolio

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease and transplant rejection. Originally founded by Dr. Gary Glick as a spin-out of the University of Michigan, Lycera is developing drug candidates that target two novel therapeutic pathways and have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents. Visit www.lycera.com for more information.


News Articles [91 Associated News Articles listed on BioPortfolio]

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

CORRECTION from Source -- Emblem Corp.

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- In Emblem’s Q2 release issued 22-Aug-2018 by Emblem Corp. over GlobeNewswire, we are advised by the company that corrections were made to the Adjusted E...

Emblem Corp. announces new board appointments

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi ...

RMMI Corp. Completes Initial Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. CA...

GTX Corp Announces Update on Corporate Strategic Plan

LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

GTX Corp Engages Doost, Inc. to Open Retail Channels

LOS ANGELES, July 19, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

Scythian Biosciences Corp. Announces Andy DeFrancesco as a New Director

TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

CORP: assessments of upper- and lower-limb muscle strength and voluntary activation in humans.

Muscle strength - the maximal force generating capacity of a muscle or group of muscles - is regularly assessed in physiological experiments and clinical trials. An understanding of the expected varia...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [42 Associated Companies listed on BioPortfolio]

Lycera Corp.

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, i...

Lycera Corporation

Lycera Corp. is focused on the discovery and development of selective, small-molecule immunomodulators for the treatment of patients with autoimmune diseases such as rheumatoid ar...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

More Information about "Lycera Corp." on BioPortfolio

We have published hundreds of Lycera Corp. news stories on BioPortfolio along with dozens of Lycera Corp. Clinical Trials and PubMed Articles about Lycera Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lycera Corp. Companies in our database. You can also find out about relevant Lycera Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...


Corporate Database Quicklinks



Searches Linking to this Company Record